Immunoassay bioanalysis service by LGC – DDS

Manufacturer LGC – DDS
LGC is an established biopharmaceutical drug development through analytical excellence with over 200 scientists across three UK facilities.


Immunoassay bioanalysis service by LGC – DDS product image
Immunoassay bioanalysis service
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

LGC's capabilities and experience cover recombinant proteins, vaccines, blood products, monoclonal antibodies, oligonucleotides, gene therapy products and more. Development and validation of bioanalytical assays to support your biopharmaceutical development programme, whether it be Pharmacokinetic (PK), Anti-Drug-Antibody (ADA), Neutralising Antibodies (nAbs) or Pharmacodynamic (PD) is core to the LGC business. 

LGC's bioanalytical services for biopharmaceuticals include: 

  • New method development Method validation (GLP, GCP or non-regulated) 
  • Sample analysis to support discovery, preclinical and clinical programmes
  • Macromolecule quantification and characterisation to support biopharmaceutical development and manufacture
  • Experienced, qualified staff and investment in the latest technologies allow us to provide high quality bioanalytical services for biopharmaceuticals in support of all stages of your development
     

Product Overview

Immunoassay bioanalysis service by LGC – DDS product image

Immunoassay bioanalysis service

Manufacturer LGC – DDS

Be the first to review this product